Leah Prentice
Overview
Explore the profile of Leah Prentice including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tessier-Cloutier B, Pors J, Thompson E, Ho J, Prentice L, McConechy M, et al.
Mod Pathol
. 2020 Aug;
34(2):508-518.
PMID: 32792599
Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma (VSCC) is an aggressive clinical entity. Current diagnostic guidelines for premalignant lesions are ambiguous, and their molecular profile and progression events are still...
2.
Pors J, Ho J, Prentice L, Thompson E, Cochrane D, Gibbard E, et al.
Am J Surg Pathol
. 2019 Nov;
44(4):495-502.
PMID: 31714258
Mesonephric carcinoma is a rare malignancy, thought to derive from Wolffian remnants. To date, no targeted molecular therapeutic options have been identified. On the basis of limited case reports, c-KIT...
3.
Burleigh A, McKinney S, Brimhall J, Yap D, Eirew P, Poon S, et al.
Breast Cancer Res
. 2015 Jan;
17:4.
PMID: 25572802
Introduction: The extracellular signals regulating mammary epithelial cell growth are of relevance to understanding the pathophysiology of mammary epithelia, yet they remain poorly characterized. In this study, we applied an...
4.
Kobel M, Kalloger S, Lee S, Duggan M, Kelemen L, Prentice L, et al.
Cancer Epidemiol Biomarkers Prev
. 2013 Jul;
22(10):1677-86.
PMID: 23880734
Background: Ovarian carcinoma is composed of five major histologic types, which associate with outcome and predict therapeutic response. Our aim was to evaluate histologic type assessments across the centers participating...
5.
McConechy M, Ding J, Cheang M, Wiegand K, Senz J, Tone A, et al.
J Pathol
. 2012 Jun;
228(1):20-30.
PMID: 22653804
The classification of endometrial carcinomas is based on pathological assessment of tumour cell type; the different cell types (endometrioid, serous, carcinosarcoma, mixed, undifferentiated, and clear cell) are associated with distinct...
6.
Heravi-Moussavi A, Anglesio M, Cheng S, Senz J, Yang W, Prentice L, et al.
N Engl J Med
. 2011 Dec;
366(3):234-42.
PMID: 22187960
Background: Germline truncating mutations in DICER1, an endoribonuclease in the RNase III family that is essential for processing microRNAs, have been observed in families with the pleuropulmonary blastoma-family tumor and...
7.
Wiegand K, Shah S, Al-Agha O, Zhao Y, Tse K, Zeng T, et al.
N Engl J Med
. 2010 Oct;
363(16):1532-43.
PMID: 20942669
Background: Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described. Methods: We sequenced the whole transcriptomes of 18...
8.
Shah S, Morin R, Khattra J, Prentice L, Pugh T, Burleigh A, et al.
Nature
. 2009 Oct;
461(7265):809-13.
PMID: 19812674
Recent advances in next generation sequencing have made it possible to precisely characterize all somatic coding mutations that occur during the development and progression of individual cancers. Here we used...
9.
Somasiri A, Nielsen J, Makretsov N, McCoy M, Prentice L, Gilks C, et al.
Cancer Res
. 2004 Aug;
64(15):5068-73.
PMID: 15289306
Podocalyxin is a CD34-related cell surface molecule with anti-adhesive qualities. We probed a tissue microarray (n = 272) linked to long-term outcome data and found that podocalyxin was highly overexpressed...